Multimorbidity in patients with chronic migraine and medication overuse headache
Acta Neurologica Scandinavica2018Vol. 138(6), pp. 515–522
Citations Over TimeTop 10% of 2018 papers
Domenico D’Amico, Emanuela Sansone, Licia Grazzi, Ambra Mara Giovannetti, Matilde Leonardi, Silvia Schiavolin, Alberto Raggi
Abstract
Recognizing multimorbidity in patients with CM-MOH is important to enhance the management of these complex patients, who are at risk of polypharmacy and increased health care utilization.
Related Papers
- → Episodic and Chronic Migraine Headache: Breaking Down Barriers to Optimal Treatment and Prevention(2015)316 cited
- → Hypersensitivity to calcitonin gene-related peptide in chronic migraine(2020)38 cited
- → Erenumab in chronic migraine: Experience from a UK tertiary centre and comparison with other real‐world evidence(2022)17 cited
- → Field Testing Alternative Criteria for Chronic Migraine(2006)58 cited
- → The Face of Chronic Migraine Which Has Started to be Clarified.(2013)4 cited